Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?
Yom
Sue S
SS
Department of Radiation Oncology, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
Rosenthal
David I
DI
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002945:Cisplatin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy* / Q000601:surgery; D006801:Humans
D000970:Antineoplastic Agents; D002945:Cisplatin